This selective review on the treatment of schizophrenia provides an update on two important issues. Firstly, new antipsychotic drugs have improved the quality of life for people with schizophrenia. This review outlines some practical issues surrounding the use of these drugs. Secondly, evidence suggests that the prompt identification and treatment of people with psychoses (including schizophrenia and affective psychoses) results in improved clinical outcomes.1 The important role that general practitioners can play in reducing the duration of untreated psychosis is also discussed.
Originally published as: Fortnightly review: Treatment of schizophrenia John McGrath, W Brett Emmerson BMJ 1999;319:1045-1048 Copyright 1999 BMJ Publishing. All rights reserved. Reproduced with permission.
Critical review of research, literature review, critical commentary